Vice President, Clinical Research at AsclepiX Therapeutics
Prior to joining AsclepiX Therapeutics, Dr. Sheng served as Sr. Director of Clinical Research and Drug Safety at Aerie Pharmaceuticals, where she was responsible for the development and implementation of clinical research and drug safety surveillance strategy for glaucoma and retinal diseases, and the management and oversight of the clinical development and drug safety programs. Prior to her tenure at Aerie, Dr. Sheng held research and development ophthalmology leadership positions at Alcon and Johnson & Johnson. Dr. Sheng is an ophthalmologist by training and holds a Ph. D in Vision Science from the Ohio State University, College of Optometry, Columbus, Ohio.
Vice President, Clinical Research